QuidelOrtho Corp·4

Mar 31, 4:14 PM ET

Busky Joseph M. 4

4 · QuidelOrtho Corp · Filed Mar 31, 2026

Research Summary

AI-generated summary of this filing

Updated

QuidelOrtho (QDEL) CFO Joseph Busky Receives RSU Award; Shares Withheld

What Happened

  • Joseph M. Busky, Chief Financial Officer of QuidelOrtho Corporation (QDEL), had 4,925 restricted stock units (RSUs) release/convert into 4,925 common shares on March 28, 2026 (reported as an award/acquisition). Of those shares, 1,519 were withheld by the company to satisfy tax-withholding obligations at a price of $14.78 per share, resulting in $22,451 withheld. The RSU conversion/exercise shows no cash exercise price.

Key Details

  • Transaction date: March 28, 2026; filing date: March 31, 2026 (appears timely).
  • Award/Acquisition (code A): 4,925 RSUs released → 4,925 shares @ $0.00.
  • Exercise/Conversion (code M): 4,925 derivative units converted to shares (reported with $0.00 exercise price).
  • Tax withholding (code F): 1,519 shares surrendered/withheld at $14.78 = $22,451 to satisfy tax obligations.
  • Footnotes: RSUs were previously reported; each RSU equals one share. A total of 14,775 shares were subject to vesting in equal installments on Mar 28 of 2024, 2025 and 2026 (4,925 each year). The disposition was the issuer withholding shares for taxes.
  • Shares owned after the transaction: not specified in the information provided in your summary.

Context

  • This was not an open-market sale but a standard RSU vesting with share withholding to cover taxes (a routine administrative action, not necessarily a market sentiment signal).
  • The filing shows conversion of RSUs into shares with a portion withheld (cashless share withholding), not a voluntary sale by the insider.

Insider Transaction Report

Form 4
Period: 2026-03-28
Busky Joseph M.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-28+4,92546,337 total
  • Tax Payment

    Common Stock

    [F2]
    2026-03-28$14.78/sh1,519$22,45144,818 total
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F4]
    2026-03-284,9250 total
    Common Stock (4,925 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    10,290
Footnotes (4)
  • [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
  • [F2]Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
  • [F3]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • [F4]14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026.
Signature
/s/ Phillip S. Askim, attorney-in-fact for Joseph M. Busky|2026-03-31

Documents

1 file
  • 4
    wk-form4_1774988038.xmlPrimary

    FORM 4